Patient Preferences to Assess Value IN Gene Therapies: Protocol Development for the PAVING Study in Hemophilia

Introduction: Gene therapies are innovative therapies that are increasingly being developed. However, health technology assessment (HTA) and payer decision making on these therapies is impeded by uncertainties, especially regarding long-term outcomes. Through measuring patient preferences regarding...

Descripción completa

Detalles Bibliográficos
Autores principales: van Overbeeke, Eline, Hauber, Brett, Michelsen, Sissel, Goldman, Michel, Simoens, Steven, Huys, Isabelle
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7985056/
https://www.ncbi.nlm.nih.gov/pubmed/33768101
http://dx.doi.org/10.3389/fmed.2021.595797

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7985056/
https://www.ncbi.nlm.nih.gov/pubmed/33768101
http://dx.doi.org/10.3389/fmed.2021.595797

Ejemplares similares